share_log

Coloplast Agrees to Buy Atos Medical From PAI Partners for EUR2.16 Bln

Coloplast Agrees to Buy Atos Medical From PAI Partners for EUR2.16 Bln

Colplast同意以21.6億歐元從PAI Partners手中收購Atos Medical
Dow Jones Newswires ·  2021/11/08 02:40

By Dominic Chopping

多米尼克·切普著

Danish medical-device and services provider Coloplast AS said Monday that it has agreed to acquire Atos Medical from French private-equity firm PAI Partners in a deal worth 2.16 billion euros ($2.5 billion).

丹麥醫療器械和服務提供商Colopast as週一表示，已同意從法國私募股權公司PAI Partners手中收購Atos Medical，交易價值21.6億歐元(合25億美元)。

Atos Medical supplies specialist medical equipment for laryngectomy--the removal of the larynx--and related care for people living with a neck stoma, an opening in the neck that allows patients to breathe.

阿託斯醫療公司為喉部切除(即切除喉部)提供專門的醫療設備，併為頸部吻合口患者提供相關護理。頸部吻合口是頸部的一個開口，可以讓患者呼吸。

"Following the expected acquisition, Coloplast gains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure," Coloplast said.

Colopast説：“在預期的收購之後，Colopast將獲得一個新的慢性護理部門，該部門將作為一個獨立的戰略業務部門運營，在共享的Colopast基礎設施上運營。”

Headquartered in Sweden, Atos Medical serves customers in around 90 countries and has around 1,150 employees and a direct presence in 30 countries. For the year ended Dec. 31, Atos Medical delivered pro forma revenue of 2.2 billion Swedish kronor ($256.4 million) and adjusted pro forma earnings before interest, tax, depreciation and amortization of SEK800 million.

Atos Medical總部設在瑞典，為大約90個國家和地區的客户提供服務，擁有約1150名員工，在30個國家和地區設有直接分支機構。在截至12月31日的一年中，Atos Medical實現了22億瑞典克朗(合2.564億美元)的預計收入，調整後的預計利息、税項、折舊和攤銷前收益(EBITDA)為8億瑞典克朗。

Write to Dominic Chopping at dominic.chopping@wsj.com

寫信給多米尼克·切普林，電子郵件：domic.choping@wsj.com

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論